Current Environment: Production

617-355-7584
Location Page
/programs/pediatric-hospital-medicine

Education

Medical School

Medical School

University of Connecticut School of Medicine, CT

Internship

Morgan Stanley Children's Hospital/ Columbia University

New York, NY

Residency

Morgan Stanley Children's Hospital/ Columbia University

New York, NY

Fellowship

Children's Hospital at Montefiore

Bronx, NY

Education

Undergraduate School

Haverford College

1991, Haverford, PA

Graduate School

Duke University School of Medicine

Durham, NC

Graduate School

MPH

Harvard School of Public Health

Boston, MA

Medical School

Duke University School of Medicine

1996, Durham, NC

Internship

Pediatrics

Boston Combined Residency Program (BCRP)

1997, Boston, MA

Residency

Pediatrics

Boston Combined Residency Program (BCRP)

1999, Boston, MA

Fellowship

Combined Fellowship in Adolescent and Division of General Pediatrics

Boston Children's Hospital

2002, Boston, MA

Publications

  1. Pediatric Mental Health Boarding: 2017 to 2023. Pediatrics. 2025 Feb 13. View Abstract

  2. Nirsevimab decreased the subsequent risk of respiratory syncytial virus infection and wheezing in the 2023-2024 RSV season. Pediatr Res. 2025 Jan 09. View Abstract

  3. Increasing Incidence of Serious Head and Neck Infections among Children in the United States, 2018-2023. J Pediatr. 2025 Apr; 279:114458. View Abstract

  4. Integrated nasopharyngeal airway metagenome and asthma genetic risk endotyping of severe bronchiolitis in infancy and risk of childhood asthma. Eur Respir J. 2024 Dec; 64(6). View Abstract

  5. Integrated-omics analysis with explainable deep networks on pathobiology of infant bronchiolitis. NPJ Syst Biol Appl. 2024 Aug 22; 10(1):93. View Abstract

  6. Influenza and COVID-19 Vaccination Rates Among Children Receiving Long-Term Ventilation. JAMA Netw Open. 2024 08 01; 7(8):e2430989. View Abstract

  7. Nasal microRNA signatures for disease severity in infants with respiratory syncytial virus bronchiolitis: a multicentre prospective study. BMJ Open Respir Res. 2024 Jul 31; 11(1). View Abstract

  8. Race-Neutral Equations and Pulmonary Function Test Interpretation in Two Pediatric Cohorts. J Pediatr. 2024 Oct; 273:114124. View Abstract

  9. Misclassification of Both Influenza Infection and Oseltamivir Exposure Status in Administrative Data. JAMA Pediatr. 2024 Feb 01; 178(2):201-203. View Abstract

  10. Trends in emergency department visits for bronchiolitis, 1993-2019. Pediatr Pulmonol. 2024 Apr; 59(4):930-937. View Abstract

  11. Respiratory Virus-Specific Nasopharyngeal Lipidome Signatures and Severity in Infants With Bronchiolitis: A Prospective Multicenter Study. J Infect Dis. 2023 11 11; 228(10):1410-1420. View Abstract

  12. Questionable Safety of Proton Pump Inhibitor Use in Children. JAMA Pediatr. 2023 Oct 01; 177(10):1010-1012. View Abstract

  13. Association between severe bronchiolitis in infancy and age 6-year lung function. Respir Med. 2023 11; 218:107401. View Abstract

  14. Nasopharyngeal fungal subtypes of infant bronchiolitis and disease severity risk. EBioMedicine. 2023 Sep; 95:104742. View Abstract

  15. Association between Early Childhood Vitamin D Status and Age 6-Year Lung Function among Children with a History of Severe Bronchiolitis in Infancy. Nutrients. 2023 May 19; 15(10). View Abstract

  16. Factors associated with mild bronchiolitis in young infants. J Am Coll Emerg Physicians Open. 2023 Jun; 4(3):e12966. View Abstract

  17. Immunoglobulin E-virus phenotypes of infant bronchiolitis and risk of childhood asthma. Front Immunol. 2023; 14:1187065. View Abstract

  18. Recurrent wheezing phenotypes after severe bronchiolitis and progression to asthma. J Allergy Clin Immunol Glob. 2023 Feb; 2(1):84-87. View Abstract

  19. Integrated relationship of nasopharyngeal airway host response and microbiome associates with bronchiolitis severity. Nat Commun. 2022 08 30; 13(1):4970. View Abstract

  20. Association of Nasopharyngeal and Serum Glutathione Metabolism with Bronchiolitis Severity and Asthma Risk: A Prospective Multicenter Cohort Study. Metabolites. 2022 Jul 22; 12(8). View Abstract

  21. Nasopharyngeal metatranscriptome profiles of infants with bronchiolitis and risk of childhood asthma: a multicentre prospective study. Eur Respir J. 2022 07; 60(1). View Abstract

  22. Total immunoglobulin E in infant bronchiolitis and risk of developing asthma. J Allergy Clin Immunol Pract. 2022 10; 10(10):2761-2763.e2. View Abstract

  23. Airway Bacterial Colonization, Biofilms and Blooms, and Acute Respiratory Infection. Pediatr Crit Care Med. 2022 10 01; 23(10):e476-e482. View Abstract

  24. Proteomics endotyping of infants with severe bronchiolitis and risk of childhood asthma. Allergy. 2022 11; 77(11):3350-3361. View Abstract

  25. COVID-19-Associated Croup in Children. Pediatrics. 2022 06 01; 149(6). View Abstract

  26. Nasopharyngeal airway dual-transcriptome of infants with severe bronchiolitis and risk of childhood asthma: A multicenter prospective study. J Allergy Clin Immunol. 2022 10; 150(4):806-816. View Abstract

  27. Confirming racial/ethnic disparities in the management of severe bronchiolitis. Am J Emerg Med. 2022 08; 58:333-335. View Abstract

  28. Bacterial Signatures of Paediatric Respiratory Disease: An Individual Participant Data Meta-Analysis. Front Microbiol. 2021; 12:711134. View Abstract

  29. Role of nasal microbiota and host response in infants with respiratory syncytial virus infection: Causal questions about respiratory outcomes. J Allergy Clin Immunol. 2022 03; 149(3):898-900. View Abstract

  30. Serum Soluble Receptor for Advanced Glycation End Products in Infants With Bronchiolitis: Associations With Acute Severity and Recurrent Wheeze. Clin Infect Dis. 2021 11 02; 73(9):e2665-e2672. View Abstract

  31. Severe bronchiolitis profiles and risk of asthma development in Finnish children. J Allergy Clin Immunol. 2022 04; 149(4):1281-1285.e1. View Abstract

  32. Late Pre-term Infants with Severe Bronchiolitis and Risk of Asthma by Age 5 Years. J Pediatr. 2022 02; 241:247-250.e1. View Abstract

  33. Urinary Tract Infections in Children with Vesicoureteral Reflux Are Accompanied by Alterations in Urinary Microbiota and Metabolome Profiles. Eur Urol. 2022 02; 81(2):151-154. View Abstract

  34. Proteome signature difference between respiratory viruses is associated with severity of bronchiolitis. Pediatr Allergy Immunol. 2021 11; 32(8):1869-1872. View Abstract

  35. Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma. Nat Commun. 2021 06 14; 12(1):3601. View Abstract

  36. Utility of Inflammatory Markers in Hospitalized Children With Skin Erythema. Hosp Pediatr. 2021 06; 11(6):627-631. View Abstract

  37. Integrated associations of nasopharyngeal and serum metabolome with bronchiolitis severity and asthma: A multicenter prospective cohort study. Pediatr Allergy Immunol. 2021 07; 32(5):905-916. View Abstract

  38. Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing. J Infect Dis. 2021 02 03; 223(2):268-277. View Abstract

  39. A joint modeling approach for longitudinal microbiome data improves ability to detect microbiome associations with disease. PLoS Comput Biol. 2020 12; 16(12):e1008473. View Abstract

  40. Integrated-omics endotyping of infants with rhinovirus bronchiolitis and risk of childhood asthma. J Allergy Clin Immunol. 2021 06; 147(6):2108-2117. View Abstract

  41. Pediatric Hospitalizations During the COVID-19 Pandemic. Pediatrics. 2020 12; 146(6). View Abstract

  42. A comparison of childhood asthma case definitions based on parent-reported data. Ann Epidemiol. 2021 03; 55:64-68.e4. View Abstract

  43. Association of endemic coronaviruses with nasopharyngeal metabolome and microbiota among infants with severe bronchiolitis: a prospective multicenter study. Pediatr Res. 2021 05; 89(7):1594-1597. View Abstract

  44. Being Mindful About Follow-up Care After Pediatric Hospitalization for Bronchiolitis. JAMA Pediatr. 2020 09 01; 174(9):e201945. View Abstract

  45. Machine learning-based prediction of acute severity in infants hospitalized for bronchiolitis: a multicenter prospective study. Sci Rep. 2020 07 03; 10(1):10979. View Abstract

  46. Respiratory viruses are associated with serum metabolome among infants hospitalized for bronchiolitis: A multicenter study. Pediatr Allergy Immunol. 2020 10; 31(7):755-766. View Abstract

  47. Severe Coronavirus Bronchiolitis in the Pre-COVID-19 Era. Pediatrics. 2020 09; 146(3). View Abstract

  48. Association of rhinovirus species with nasopharyngeal metabolome in bronchiolitis infants: A multicenter study. Allergy. 2020 09; 75(9):2379-2383. View Abstract

  49. In infants with severe bronchiolitis: dual-transcriptomic profiling of nasopharyngeal microbiome and host response. Pediatr Res. 2020 08; 88(2):144-146. View Abstract

  50. Increased Moraxella and Streptococcus species abundance after severe bronchiolitis is associated with recurrent wheezing. J Allergy Clin Immunol. 2020 02; 145(2):518-527.e8. View Abstract

  51. Trends in Bronchiolitis Hospitalizations in the United States: 2000-2016. Pediatrics. 2019 12; 144(6). View Abstract

  52. Bronchiolitis severity is related to recurrent wheezing by age 3 years in a prospective, multicenter cohort. Pediatr Res. 2020 02; 87(3):428-430. View Abstract

  53. Respiratory Virus Epidemiology Among US Infants With Severe Bronchiolitis: Analysis of 2 Multicenter, Multiyear Cohort Studies. Pediatr Infect Dis J. 2019 08; 38(8):e180-e183. View Abstract

  54. Association of respiratory viruses with serum metabolome in infants with severe bronchiolitis. Pediatr Allergy Immunol. 2019 12; 30(8):848-851. View Abstract

  55. Association of Serum Albumin With Apnea in Infants With Bronchiolitis: A Secondary Analysis of Data From the MARC-35 Study. JAMA Netw Open. 2019 07 03; 2(7):e197100. View Abstract

  56. Association of Rhinovirus C Bronchiolitis and Immunoglobulin E Sensitization During Infancy With Development of Recurrent Wheeze. JAMA Pediatr. 2019 06 01; 173(6):544-552. View Abstract

  57. Serum Metabolome Is Associated With the Nasopharyngeal Microbiota and Disease Severity Among Infants With Bronchiolitis. J Infect Dis. 2019 05 24; 219(12):2005-2014. View Abstract

  58. Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis. J Infect Dis. 2019 05 05; 219(11):1804-1808. View Abstract

  59. Rhinovirus Species in Children With Severe Bronchiolitis: Multicenter Cohort Studies in the United States and Finland. Pediatr Infect Dis J. 2019 03; 38(3):e59-e62. View Abstract

  60. Association of type 2 cytokines in severe rhinovirus bronchiolitis during infancy with risk of developing asthma: A multicenter prospective study. Allergy. 2019 07; 74(7):1374-1377. View Abstract

  61. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J Allergy Clin Immunol. 2019 05; 143(5):1925-1928.e7. View Abstract

  62. Circulating 25-hydroxyvitamin D, nasopharyngeal microbiota, and bronchiolitis severity. Pediatr Allergy Immunol. 2018 12; 29(8):877-880. View Abstract

  63. Tracheal Microbiota in Patients With a Tracheostomy Before, During and After an Acute Respiratory Infection. Pediatr Infect Dis J. 2018 11; 37(11):e269-e271. View Abstract

  64. Vitamin D Status at the Time of Hospitalization for Bronchiolitis and Its Association with Disease Severity. J Pediatr. 2018 12; 203:416-422.e1. View Abstract

  65. Severe bronchiolitis profiles and risk of recurrent wheeze by age 3 years. J Allergy Clin Immunol. 2019 04; 143(4):1371-1379.e7. View Abstract

  66. Overcoming the Bronchiolitis Blues: Embracing Global Collaboration and Disease Heterogeneity. Pediatrics. 2018 09; 142(3). View Abstract

  67. Nasopharyngeal CCL5 in infants with severe bronchiolitis and risk of recurrent wheezing: A multi-center prospective cohort study. Clin Exp Allergy. 2018 08; 48(8):1063-1067. View Abstract

  68. Serum 25-hydroxyvitamin D, metabolome, and bronchiolitis severity among infants-A multicenter cohort study. Pediatr Allergy Immunol. 2018 06; 29(4):441-445. View Abstract

  69. Multicenter Study of Albuterol Use Among Infants Hospitalized with Bronchiolitis. West J Emerg Med. 2018 May; 19(3):475-483. View Abstract

  70. Respiratory Syncytial Virus and Rhinovirus Bronchiolitis Are Associated With Distinct Metabolic Pathways. J Infect Dis. 2018 03 13; 217(7):1160-1169. View Abstract

  71. Circulating 25-hydroxyvitamin D, nasopharyngeal airway metabolome, and bronchiolitis severity. Allergy. 2018 05; 73(5):1135-1140. View Abstract

  72. RSV vs. rhinovirus bronchiolitis: difference in nasal airway microRNA profiles and NF?B signaling. Pediatr Res. 2018 03; 83(3):606-614. View Abstract

  73. The association between anterior nares and nasopharyngeal microbiota in infants hospitalized for bronchiolitis. Microbiome. 2018 01 03; 6(1):2. View Abstract

  74. Nasal Airway Microbiota Profile and Severe Bronchiolitis in Infants: A Case-control Study. Pediatr Infect Dis J. 2017 Nov; 36(11):1044-1051. View Abstract

  75. Associations of Nasopharyngeal Metabolome and Microbiome with Severity among Infants with Bronchiolitis. A Multiomic Analysis. Am J Respir Crit Care Med. 2017 10 01; 196(7):882-891. View Abstract

  76. Serum LL-37 Levels Associated With Severity of Bronchiolitis and Viral Etiology. Clin Infect Dis. 2017 Sep 15; 65(6):967-975. View Abstract

  77. The temporal dynamics of the tracheal microbiome in tracheostomised patients with and without lower respiratory infections. PLoS One. 2017; 12(8):e0182520. View Abstract

  78. Clinical Profiles of Respiratory Syncytial Virus Subtypes A AND B Among Children Hospitalized with Bronchiolitis. Pediatr Infect Dis J. 2017 08; 36(8):808-810. View Abstract

  79. Multicenter Observational Study of the Use of Nebulized Hypertonic Saline to Treat Children Hospitalized for Bronchiolitis From 2008 to 2014. Hosp Pediatr. 2017 Jul 31. View Abstract

  80. Sphingolipid metabolism potential in fecal microbiome and bronchiolitis in infants: a case-control study. BMC Res Notes. 2017 Jul 26; 10(1):325. View Abstract

  81. The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis. Allergy. 2017 Nov; 72(11):1796-1800. View Abstract

  82. Household siblings and nasal and fecal microbiota in infants. Pediatr Int. 2017 Apr; 59(4):473-481. View Abstract

  83. Serum cathelicidin, nasopharyngeal microbiota, and disease severity among infants hospitalized with bronchiolitis. J Allergy Clin Immunol. 2017 04; 139(4):1383-1386.e6. View Abstract

  84. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis. Eur Respir J. 2016 11; 48(5):1329-1339. View Abstract

  85. The Fecal Microbiota Profile and Bronchiolitis in Infants. Pediatrics. 2016 07; 138(1). View Abstract

  86. A clustering approach to identify severe bronchiolitis profiles in children. Thorax. 2016 08; 71(8):712-8. View Abstract

  87. Trends in Infectious Disease Hospitalizations in US Children, 2000 to 2012. Pediatr Infect Dis J. 2016 06; 35(6):e158-63. View Abstract

  88. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol. 2016 06; 137(6):1909-1913.e4. View Abstract

  89. Children Hospitalized with Rhinovirus Bronchiolitis Have Asthma-Like Characteristics. J Pediatr. 2016 05; 172:202-204.e1. View Abstract

  90. Detection of respiratory syncytial virus and rhinovirus in healthy infants. BMC Res Notes. 2015 Nov 25; 8:718. View Abstract

  91. Prenatal Versus Postnatal Tobacco Smoke Exposure and Intensive Care Use in Children Hospitalized With Bronchiolitis. Acad Pediatr. 2016 07; 16(5):446-452. View Abstract

  92. Clinical Endpoints for Respiratory Syncytial Virus Prophylaxis Trials in Infants and Children in High-income and Middle-income Countries. Pediatr Infect Dis J. 2015 Oct; 34(10):1086-92. View Abstract

  93. Eligibility for palivizumab prophylaxis in a cohort of children with severe bronchiolitis. Pediatr Int. 2015 Oct; 57(5):1031-4. View Abstract

  94. Association Between Hyponatremia and Higher Bronchiolitis Severity Among Children in the ICU With Bronchiolitis. Hosp Pediatr. 2015 Jul; 5(7):385-9. View Abstract

  95. Bordetella pertussis is an uncommon pathogen in children hospitalized with bronchiolitis during the winter season. Pediatr Infect Dis J. 2015 Jun; 34(6):566-70. View Abstract

  96. Use of Cough and Cold Medications in Severe Bronchiolitis before and after a Health Advisory Warning against Their Use. J Pediatr. 2015 Jul; 167(1):196-8.e1-2. View Abstract

  97. Variability of intensive care management for children with bronchiolitis. Hosp Pediatr. 2015 Apr; 5(4):175-84. View Abstract

  98. Rhinovirus-induced bronchiolitis: Lack of association between virus genomic load and short-term outcomes. J Allergy Clin Immunol. 2015 Aug; 136(2):509-12.e11. View Abstract

  99. Hospital course and discharge criteria for children hospitalized with bronchiolitis. J Hosp Med. 2015 Apr; 10(4):205-11. View Abstract

  100. Risk factors for requiring intensive care among children admitted to ward with bronchiolitis. Acad Pediatr. 2015 Jan-Feb; 15(1):77-81. View Abstract

  101. Respiratory syncytial virus genomic load and disease severity among children hospitalized with bronchiolitis: multicenter cohort studies in the United States and Finland. J Infect Dis. 2015 May 15; 211(10):1550-9. View Abstract

  102. Variability in inpatient management of children hospitalized with bronchiolitis. Acad Pediatr. 2015 Jan-Feb; 15(1):69-76. View Abstract

  103. Hospital length-of-stay is associated with rhinovirus etiology of bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):829-34. View Abstract

  104. Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis. Pediatr Infect Dis J. 2014 Aug; 33(8):809-13. View Abstract

  105. Racial/ethnic differences in the presentation and management of severe bronchiolitis. J Hosp Med. 2014 Sep; 9(9):565-72. View Abstract

  106. Recent evidence on the management of bronchiolitis. Curr Opin Pediatr. 2014 Jun; 26(3):328-33. View Abstract

  107. Infectious pathogens and bronchiolitis outcomes. Expert Rev Anti Infect Ther. 2014 Jul; 12(7):817-28. View Abstract

  108. Temporal trends in emergency department visits for bronchiolitis in the United States, 2006 to 2010. Pediatr Infect Dis J. 2014 Jan; 33(1):11-8. View Abstract

  109. Nasopharyngeal Proteobacteria are associated with viral etiology and acute wheezing in children with severe bronchiolitis. J Allergy Clin Immunol. 2014 Apr; 133(4):1220-2. View Abstract

  110. Apnea in children hospitalized with bronchiolitis. Pediatrics. 2013 Nov; 132(5):e1194-201. View Abstract

  111. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics. 2013 Jul; 132(1):28-36. View Abstract

  112. Altitude and environmental climate effects on bronchiolitis severity among children presenting to the emergency department. J Environ Health. 2012 Oct; 75(3):8-15; quiz 54. View Abstract

  113. Serum cathelicidin level is associated with viral etiology and severity of bronchiolitis. J Allergy Clin Immunol. 2012 Oct; 130(4):1007-8.e1. View Abstract

  114. Prospective multicenter study of children with bronchiolitis requiring mechanical ventilation. Pediatrics. 2012 Sep; 130(3):e492-500. View Abstract

  115. Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):700-6. View Abstract

  116. Nasopharyngeal lactate dehydrogenase concentrations predict bronchiolitis severity in a prospective multicenter emergency department study. Pediatr Infect Dis J. 2012 Jul; 31(7):767-9. View Abstract

  117. National study of antibiotic use in emergency department visits for pneumonia, 1993 through 2008. Acad Emerg Med. 2012 May; 19(5):562-8. View Abstract

  118. Serum 25-hydroxyvitamin D levels among Boston trainee doctors in winter. Nutrients. 2012 03; 4(3):197-207. View Abstract

  119. Clinical features can help predict which infants with bronchiolitis will need hospital admission. J Pediatr. 2012 Jan; 160(1):174-5. View Abstract

  120. Low serum 25-hydroxyvitamin D levels are associated with increased risk of viral coinfections in wheezing children. J Allergy Clin Immunol. 2010 Nov; 126(5):1074-6, 1076.e1-4. View Abstract

  121. Insurance status and the variable management of children presenting to the emergency department with bronchiolitis. Pediatr Emerg Care. 2010 Oct; 26(10):716-21. View Abstract

  122. Prospective multicenter study of bronchiolitis: predictors of an unscheduled visit after discharge from the emergency department. Acad Emerg Med. 2010 Apr; 17(4):376-82. View Abstract

  123. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol. 2010 May; 202(5):436.e1-8. View Abstract

  124. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med. 2009 Dec; 29(4):741-55. View Abstract

  125. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics. 2009 Nov; 124(5):1404-10. View Abstract

  126. Factors associated with longer emergency department length of stay for children with bronchiolitis : a prospective multicenter study. Pediatr Emerg Care. 2009 Oct; 25(10):636-41. View Abstract

  127. Variability in the diagnostic labeling of nonbacterial lower respiratory tract infections: a multicenter study of children who presented to the emergency department. Pediatrics. 2009 Apr; 123(4):e573-81. View Abstract

  128. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009 Feb 23; 169(4):384-90. View Abstract

  129. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep. 2009 Jan; 9(1):81-7. View Abstract

  130. Prospective multicenter bronchiolitis study: predicting intensive care unit admissions. Acad Emerg Med. 2008 Oct; 15(10):887-94. View Abstract

  131. Bronchiolitis: lingering questions about its definition and the potential role of vitamin D. Pediatrics. 2008 Jul; 122(1):177-9. View Abstract

  132. Variations in admission practices for adolescents with anorexia nervosa: a North American sample. J Adolesc Health. 2008 Nov; 43(5):425-31. View Abstract

  133. Prospective multicenter study of bronchiolitis: predicting safe discharges from the emergency department. Pediatrics. 2008 Apr; 121(4):680-8. View Abstract

  134. Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med. 2008 Feb; 15(2):111-8. View Abstract

  135. US outpatient office visits for bronchiolitis, 1993-2004. Ambul Pediatr. 2007 Jul-Aug; 7(4):304-7. View Abstract

  136. Evaluation of compliance with palivizumab recommendations in a multicenter study of young children presenting to the emergency department with bronchiolitis. Pediatr Emerg Care. 2007 Jun; 23(6):362-7. View Abstract

  137. Variation in IRB responses to a standard, observational pediatric research protocol. Academic Emergency Medicine. 2007; 14(4):377-380.

  138. Variation in institutional review board responses to a standard, observational, pediatric research protocol. Acad Emerg Med. 2007 Apr; 14(4):377-80. View Abstract

  139. Evidence Based Medicine. Comprehensive Pediatric Hospital Medicine. Zauoutis LB, Chiang VW, editors. 2007; 32-35.

  140. U.S. Outpatient office visits for bronchiolitis, 1993-2004. Ambulatory Pediatrics. 2007; 7(4):304-307.

  141. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics. 2006 Dec; 118(6):2418-23. View Abstract

  142. Multicenter Study of Bronchiolitis in the Emergency Department. Oral Presentation. American Academy of Pediatrics National Convention and Exhibition. 2006.

  143. Testicular torsion and risk factors for orchiectomy. Arch Pediatr Adolesc Med. 2005 Dec; 159(12):1167-71. View Abstract

  144. Bronchiolitis in US emergency departments 1992 to 2000: epidemiology and practice variation. Pediatr Emerg Care. 2005 Apr; 21(4):242-7. View Abstract

  145. Variation in Admission for Adolescents with Anorexia Nervosa: A North American Sample. Poster. Society for Adolescent Medicine Annual Conference. 2005.

  146. Two children with Lyme disease presenting with persistent headache. Pediatrics. 2003; 112: e477-e479. Reprinted in Review Series Neurology. 2004; 2:10-12.

  147. Lyme disease presenting with persistent headache. Pediatrics. 2003 Dec; 112(6 Pt 1):e477-9. View Abstract

  148. Which psychiatric patients board on the medical service? Pediatrics. 2003 Jun; 111(6 Pt 1):e693-8. View Abstract

  149. A practical guide to prescribing oral contraceptives. Contemporary Pediatrics. 2001; 18(10):111-126. Reprinted in Contemporary OB/GYN. 2001; 46(11):87-104 and Patient Care [serial online] June. 2003.

  150. Optimizing the care of hospitalized youth. Poster. Society for Adolescent Medicine Annual Conference. 2002.

  151. Demystifying delayed puberty. Contemporary Pediatrics. 2001; 18(4): 43-60. Reprinted in Contemporary OB/GYN. 2001; 46(8):39-54.

  152. New seizures in a 6 year-old: Expanding Horizons. Contemporary Pediatrics. 1999; 16(8):25-33.

  153. Phenobarbital selectively promotes initiated cells with reduced TGF beta receptor levels. Carcinogenesis. 1996 Jan; 17(1):171-4. View Abstract

Education

Undergraduate School

Princeton University

Princeton, CA

Medical School

University of Massachusetts Medical School

Worcester, MA

Internship

Boston Children's Hospital

Boston, MA

Residency

Boston Children's Hospital

Boston, MA

Publications

Education

Undergraduate School

University of Michigan-Flint

Flint, MI

Medical School

Cleveland Clinic Lerner College of Medicine

Cleveland, OH

Internship

Boston Boston Combined Residency Program (BCRP)

2014, Boston, MA

Residency

Boston Boston Combined Residency Program (BCRP)

2017, Boston, MA

Residency

Chief Resident

Boston Boston Combined Residency Program (BCRP)

2018, Boston, MA

Publications
Subscribe to Hospital Medicine at Boston Children's

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services